Changes in hematological and serum biochemical parameters in common marmosets (Callithrix jacchus) after inoculation with dengue virus

Journal of Medical Primatology

Volumn 41, Issue 5, 2012, Pages 289-296

  Omatsu, Tsutomu ^a   Moi, Meng Ling ^a   Takasaki, Tomohiko ^a   Nakamura, Shinichiro ^b   Katakai, Yuko ^c   Tajima, Shigeru ^a   Ito, Mikako ^a   Yoshida, Tomoyuki ^d   Saito, Akatsuki ^d   Akari, Hirofumi ^d   Kurane, Ichiro ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Biochemical parameter; Clinical sign; Common marmoset; Dengue virus; Hematological parameter

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASE; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CHEMISTRY; BODY TEMPERATURE; BODY TEMPERATURE MEASUREMENT; CALLITHRIX; CLINICAL FEATURE; CONTROLLED STUDY; DENGUE; DENGUE VIRUS; FEVER; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOPENIA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SERUM; THROMBOCYTOPENIA; UREA NITROGEN BLOOD LEVEL; VIRUS INDUCTION;

ANIMALS; BLOOD CELL COUNT; CALLITHRIX; DENGUE; DENGUE VIRUS; DISEASE MODELS, ANIMAL; MALE;

CALLITHRIX JACCHUS; DENGUE VIRUS;

EID: 84866292384     PISSN: 00472565     EISSN: 16000684     Source Type: Journal    
DOI: 10.1111/j.1600-0684.2012.00552.x     Document Type: Article

References (38)

1. WHO: Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. Geneva, Switzerland: WHO, 2009.
2. Bente DA, Rico-Hesse R: Models of dengue virus infection. Drug Discov Today Dis Models 2006; 3:97-103.
3. Koraka P, Benton S, van Amerongen G, Stittelaar KJ, Osterhaus AD: Efficacy of a live attenuated tetravalent candidate dengue vaccine in naïve and previously infected cynomolgus macaques. Vaccine 2007; 25:5409-16.
4. Bernardo L, Izquierdo A, Prado I, Rosario D, Alvarez M, Santana E, Castro J, Martínez R, Rodríguez R, Morier L, Guillén G, Guzmán MG: Primary and secondary infections of Macaca fascicularis monkeys with Asian and American genotypes of dengue virus 2. Clin Vaccine Immunol 2008; 15:439-46.
5. Blair PJ, Kochel TJ, Raviprakash K, Guevara C, Salazar M, Wu SJ, Olson JG, Porter KR: Evaluation of immunity and protective efficacy of a dengue-3 pre-membrane and envelope DNA vaccine in Aotus nancymae monkeys. Vaccine 2006; 24:1427-32.
6. Simmons JS, St John JH, Reynolds FH: Experimental studies of dengue. Philippine J Sci 1931; 44:1-252.
7. Rosen L: Experimental infection of New World monkeys with dengue and yellow fever viruses. Am J Trop Med Hyg 1958; 7:406-10.
8. Whitehead RH, Chaicumpa V, Olson LC, Russell PK: Sequential dengue virus infections in the white-handed gibbon (Hylobates lar). Am J Trop Med Hyg 1970; 19:94-102.
9. Halstead SB: In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J Infect Dis 1979; 140:527-33.
10. Onlamoon N, Noisakran S, Hsiao HM, Duncan A, Villinger F, Ansari AA, Perng GC: Dengue virus-induced hemorrhage in a nonhuman primate model. Blood 2010; 115:1823-34.
11. Paul JR, Melnick JL, Sabin AB: Experimental attempts to transmit phlebotomus (Sandfly, Pappataci) and dengue fevers to chimpanzees. Proc Soc Exp Biol Med May 1948; 68:193-8.
12. Goncalvez AP, Engle RE, St Claire M, Purcell RH, Lai CJ: Monoclonal antibody-mediated enhancement of dengue virus infection in vitro and in vivo and strategies for prevention. Proc Natl Acad Sci USA 2007; 104:9422-7.
13. Ito M, Mukai RZ, Takasaki T, Kotaki A, Kurane I: Antibody-dependent enhancement of dengue virus infection in vitro by undiluted sera from monkeys infected with heterotypic dengue virus. Arch Virol 2010; 155:1617-27.
14. Omatsu T, Moi ML, Hirayama T, Takasaki T, Nakamura S, Tajima S, Ito M, Yoshida T, Saito A, Katakai Y, Akari H, Kurane I: Common marmoset (Callithrix jacchus) as a primate model of dengue virus infection: development of high levels of viraemia and demonstration of protective immunity. J Gen Virol 2011; 92:2272-80.
15. Kurane I, Takasaki T, Yamada K: Trends in flavivirus infections in Japan. Emerg Infect Dis 2000; 6:569-71.
16. Putvatana R, Yoksan S, Chayayodhin T, Bhamarapravati N, Halstead SB: Absence of dengue 2 infection enhancement in human sera containing Japanese encephalitis antibodies. Am J Trop Med Hyg 1984; 33:288-94.
17. Moi ML, Lim CK, Kotaki A, Takasaki T, Kurane I: Detection of higher levels of dengue viremia using FcγR-expressing BHK-21 cells than FcγR-negative cells in secondary infection but not in primary infection. J Infect Dis 2011; 203:1405-14.
18. Guilarde AO, Turchi MD, Siqueira JB Jr, Feres VC, Rocha B, Levi JE, Souza VA, Boas LS, Pannuti CS, Martelli CM: Dengue and dengue hemorrhagic fever among adults: clinical outcomes related to viremia, serotypes, and antibody response. J Infect Dis 2008; 197:817-24.
19. Vaughn DW, Green S, Kalayanarooj S, Innis BL, Nimmannitya S, Suntayakorn S, Rothman AL, Ennis FA, Nisalak A: Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis 1997; 176:322-30.
20. Villar-Centeno LA, Díaz-Quijano FA, Martínez-Vega RA: Biochemical alterations as markers of dengue hemorrhagic fever. Am J Trop Med Hyg 2008; 78:370-4.
21. Brinton MA, Kurane I, Mathew A, Zeng L, Shi PY, Rothman A, Ennis FA: Immune mediated and inherited defences against flaviviruses. Clin Diagn Virol 1998; 10:129-39.
22. Halstead SB, Mahalingam S, Marovich MA, Ubol S, Mosser DM: Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis 2010; 10:712-22.
23. Ubol S, Halstead SB: How innate immune mechanisms contribute to antibody-enhanced viral infections. Clin Vaccine Immunol 2010; 17:1829-35.
24. Lan NT, Hirayama K: Host genetic susceptibility to severe dengue infection. Trop Med Health 2011; 4(Suppl):73-81.
25. Loke H, Bethell D, Phuong CX, Day N, White N, Farrar J, Hill A: Susceptibility to dengue hemorrhagic fever in vietnam: evidence of an association with variation in the vitamin d receptor and Fc gamma receptor IIa genes. Am J Trop Med Hyg 2002; 67(1):102-6.
26. Sakuntabhai A, Turbpaiboon C, Casadémont I, Chuansumrit A, Lowhnoo T, Kajaste-Rudnitski A, Kalayanarooj SM, Tangnararatchakit K, Tangthawornchaikul N, Vasanawathana S, Chaiyaratana W, Yenchitsomanus PT, Suriyaphol P, Avirutnan P, Chokephaibulkit K, Matsuda F, Yoksan S, Jacob Y, Lathrop GM, Malasit P, Desprès P, Julier C: A variant in the CD209 promoter is associated with severity of dengue disease. Nat Genet 2005; 37:507-13.
27. Silva LK, Blanton RE, Parrado AR, Melo PS, Morato VG, Reis EA, Dias JP, Castro JM, Vasconcelos PF, Goddard KA, Barreto ML, Reis MG, Teixeira MG: Dengue hemorrhagic fever is associated with polymorphisms in JAK1. Eur J Hum Genet 2010; 18:1221-7.
28. Soundravally R, Hoti SL: Immunopathogenesis of dengue hemorrhagic fever and shock syndrome: role of TAP and HPA gene polymorphism. Hum Immunol 2007; 68:973-9.
29. Fernández-Mestre MT, Gendzekhadze K, Rivas-Vetencourt P, Layrisse Z: TNF-alpha-308A allele, a possible severity risk factor of hemorrhagic manifestation in dengue fever patients. Tissue Antigens 2004; 64:469-72.
30. Perez AB, Sierra B, Garcia G, Aguirre E, Babel N, Alvarez M, Sanchez L, Valdes L, Volk HD, Guzman MG: Tumor necrosis factor-alpha, transforming growth factor-β1, and interleukin-10 gene polymorphisms: implication in protection or susceptibility to dengue hemorrhagic fever. Hum Immunol 2010; 71:1135-40.
31. Nguyen TP, Kikuchi M, Vu TQ, Do QH, Tran TT, Vo DT, Ha MT, Vo VT, Cao TP, Tran VD, Oyama T, Morita K, Yasunami M, Hirayama K: Protective and enhancing HLA alleles, HLA-DRB1*0901 and HLA-A*24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome. PLoS Negl Trop Dis 2008; 2:e304.
32. García G, del Puerto F, Pérez AB, Sierra B, Aguirre E, Kikuchi M, Sánchez L, Hirayama K, Guzmán MG: Association of MICA and MICB alleles with symptomatic dengue infection. Hum Immunol 2011; 72:904-7.
33. Wang WK, Chen HL, Yang CF, Hsieh SC, Juan CC, Chang SM, Yu CC, Lin LH, Huang JH, King CC: Slower rates of clearance of viral load and virus-containing immune complexes in patients with dengue hemorrhagic fever. Clin Infect Dis 2006; 43:1023-30.
34. Gubler DJ, Suharyono W, Tan R, Abidin M, Sie A: Viraemia in patients with naturally acquired dengue infection. Bull World Health Organ 1981; 59:623-30.
35. Thai KT, Phuong HL, Thanh Nga TT, Giao PT, Hung le Q, van Nam N, Binh TQ, Simmons C, Farrar J, Hien TT, van Doorn HR, de Jong MD, de Vries PJ: Clinical, epidemiological and virological features of Dengue virus infections in Vietnamese patients presenting to primary care facilities with acute undifferentiated fever. J Infect 2010; 60:229-37.
36. Schneider BS, Soong L, Coffey LL, Stevenson HL, McGee CE, Higgs S: Aedes aegypti Saliva Alters Leukocyte Recruitment and Cytokine Signaling by Antigen-Presenting Cells during West Nile Virus Infection. PLoS ONE 2010; 5:e11704.
37. Sabin AB: Research on dengue during world war II. Am J Trop Med Hyg 1952; 1:30-50.
38. Kanesa-thasan N, Sun W, Kim-Ahn G, van Albert S, Putnak JR, King A, Raengsakulsrach B, Christ-Schmidt H, Gilson K, Zahradnik JM, Vaughn DW, Innis BL, Saluzzo JF, Hoke CH Jr: Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers. Vaccine 2001; 19:3179-88.